Microbiological eradication of XDR Acinetobacter baumannii intra-abdominal infection using sulbactam-durobactam: clinical and microbiological outcomes amidst irreversible host comorbidities

Lei Yu, Jieli He, Waiming Chan, Shan Zou, Qingshan Zhou, Jun Jin · 2026

Read Microbiological eradication of XDR Acinetobacter baumannii intra-abdominal infection using sulbactam-durobactam: clinical and microbiological outcomes amidst irreversible host comorbidities by Lei Yu, Jieli He, Waiming Chan, Shan Zou, Qingshan Zhou, Jun Jin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13218864.txt.

Description

Lei Yu and co-authors present a case report the catalog lists under 2026. A 63-year-old man had late-stage rectal cancer and a nerve-muscle disease. After urgent bowel surgery he caught two drug-hard germs in the lung and belly. One germ resists nearly all drugs. The first rescue drug mix failed to clear the infections.

Care then switched to a newer paired drug plus a second strong drug. Lab tests showed the germs were cleared from the body. The case is set against host health problems that cannot be reversed. Infection teams get a worked example of a new drug pair in a deep belly infection. Such cases matter because trial data for the hardest germs are still thin. The report shows both the drug result and the limits set by the patient's other diseases.

Catalog record

CREATORLei Yu, Jieli He, Waiming Chan, Shan Zou, Qingshan Zhou, Jun Jin
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE17 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13218864

Browse the full library · About the Tower of Babel